Alogabat |
| Katalog-Nr.GC63495 |
Alogbat (Beispiel 8) ist ein GABAA-α5-Rezeptor-positiver allosterischer Modulator (PAMs) (aus dem Patent WO2018104419A1 entnommen).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2230009-48-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Alogabat (example 8) is a GABAA α5 receptor positive allosteric modulators (PAMs) (extracted from patent WO2018104419A1)[1].
[1]. Bernd Buettelmann, et al. New isoxazolyl ether derivatives as gaba a alpha5 pam. Patent WO2018104419A1.
Review for Alogabat
Average Rating: 5 (Based on Reviews and 9 reference(s) in Google Scholar.)
Review for Alogabat
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *